Strengthens and expands U.S. biosimilars immunology portfolio with multi-indication arthritis treatment “Biosimilars continue to be a key growth driver for Organon, and this acquisition complements ...
With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.